GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » argenx SE (BSP:A1RG34) » Definitions » Shiller PE Ratio

argenx SE (BSP:A1RG34) Shiller PE Ratio : (As of Apr. 30, 2024)


View and export this data going back to 2020. Start your Free Trial

What is argenx SE Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


argenx SE Shiller PE Ratio Historical Data

The historical data trend for argenx SE's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

argenx SE Shiller PE Ratio Chart

argenx SE Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

argenx SE Quarterly Data
Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Jun20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of argenx SE's Shiller PE Ratio

For the Biotechnology subindustry, argenx SE's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


argenx SE's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, argenx SE's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where argenx SE's Shiller PE Ratio falls into.



argenx SE Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

argenx SE's E10 for the quarter that ended in Dec. 2023 is calculated as:

For example, argenx SE's adjusted earnings per share data for the three months ended in Dec. 2023 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=-8.281/126.4000*126.4000
=-8.281

Current CPI (Dec. 2023) = 126.4000.

argenx SE Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201309 -0.015 99.080 -0.019
201312 -0.312 98.360 -0.401
201403 -0.379 99.390 -0.482
201406 -0.523 99.240 -0.666
201409 -0.260 99.960 -0.329
201412 -0.767 99.050 -0.979
201503 -0.645 99.750 -0.817
201506 -0.921 100.230 -1.161
201509 -0.861 100.500 -1.083
201512 -1.327 99.730 -1.682
201603 -0.788 100.310 -0.993
201606 -0.823 100.260 -1.038
201609 -0.961 100.570 -1.208
201612 -1.396 100.710 -1.752
201703 -1.397 101.440 -1.741
201706 -0.048 101.370 -0.060
201709 -1.160 102.030 -1.437
201712 -1.469 101.970 -1.821
201803 -2.203 102.470 -2.717
201806 -0.168 103.100 -0.206
201809 -2.187 103.950 -2.659
201812 -3.659 103.970 -4.448
201903 0.733 105.370 0.879
201906 -5.996 105.840 -7.161
201909 -2.764 106.700 -3.274
201912 -10.942 106.800 -12.950
202006 -27.032 107.510 -31.782
202012 -42.135 107.850 -49.382
202103 -4.564 108.870 -5.299
202106 9.956 109.670 11.475
202109 -23.967 110.790 -27.344
202112 -26.239 114.010 -29.091
202203 -21.697 119.460 -22.957
202206 -19.181 119.050 -20.365
202209 -22.338 126.890 -22.252
202212 -3.672 124.940 -3.715
202303 -2.708 124.720 -2.744
202306 -8.203 125.830 -8.240
202309 -6.173 127.160 -6.136
202312 -8.281 126.400 -8.281

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


argenx SE  (BSP:A1RG34) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


argenx SE Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of argenx SE's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


argenx SE (BSP:A1RG34) Business Description

Address
Laarderhoogtweg 25, Amsterdam, NH, NLD, 1101EB
Argenx is a Dutch company focused on using its antibody engineering technology to treat rare autoimmune diseases. Vyvgart (efgartigimod) was approved in the U.S. in December 2021 as a treatment for generalized myasthenia gravis, followed by approvals in Europe and Japan in 2022.

argenx SE (BSP:A1RG34) Headlines

No Headlines